Insider Shareholders with Direct Ownership of Syndax Pharmaceuticals Inc (SNDX)
This section provides a comprehensive overview of the insiders with direct ownership of Syndax Pharmaceuticals Inc (SNDX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Syndax Pharmaceuticals Inc Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Michael A Metzger
Chief Executive Officer |
683,920 | 537,670 | 163,909 $3.09 Million | 47 |
Feb 07, 2024
Added 19.22%
|
| 220,578 | 78,815 | 141,763 $2.67 Million | 10 |
Feb 07, 2024
Added 19.34%
|
|
|
Bvf Partners L P
> 10% Shareholder |
0 | 2,000,000 | 85,038 $1.6 Million | 1 |
Jun 18, 2018
Reduced 68.94%
|
| 172,000 | 107,000 | 65,000 $1.23 Million | 14 |
Feb 07, 2024
Added 20.73%
|
|
| 65,000 | 0 | 65,000 $1.23 Million | 4 |
Feb 07, 2024
Added 20.73%
|
|
| 99,000 | 34,000 | 65,000 $1.23 Million | 12 |
Feb 07, 2024
Added 20.73%
|
|
| 148,000 | 83,000 | 65,000 $1.23 Million | 6 |
Feb 07, 2024
Added 20.73%
|
|
|
Keith A. Goldan
Chief Financial Officer |
53,200 | 577 | 52,623 $992,469 | 6 |
Jun 14, 2024
Added 2.32%
|
| 49,000 | 0 | 49,000 $924,140 | 3 |
Feb 07, 2024
Added 25.76%
|
|
|
Neil Gallagher
President, Head of R&D |
47,813 | 0 | 47,813 $901,753 | 1 |
Feb 07, 2024
Added 21.54%
|
| 1,199,155 | 1,210,884 | 34,836 $657,006 | 44 |
Feb 07, 2024
Added 32.8%
|
|
| 85,515 | 53,515 | 32,000 $603,520 | 10 |
Feb 02, 2022
Added 33.33%
|
|
|
Michael L. Meyers
SVP, Chief Medical Officer |
12,550 | 0 | 23,280 $439,060 | 5 |
Jan 31, 2022
Added 6.86%
|
|
Peter Ordentlich
Chief Scientific Officer |
106,718 | 106,453 | 0 $0 | 15 |
Feb 15, 2023
Reduced 100.0%
|
|
Alexander Nolte
Chief Accounting Officer |
968 | 968 | 0 $0 | 2 |
Feb 01, 2022
Reduced 100.0%
|